Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Ranga R Krishnan"'
Autor:
Hongjie Zhu, Mikhail B Bogdanov, Stephen H Boyle, Wayne Matson, Swati Sharma, Samantha Matson, Erik Churchill, Oliver Fiehn, John A Rush, Ranga R Krishnan, Eve Pickering, Marielle Delnomdedieu, Rima Kaddurah-Daouk, Pharmacometabolomics Research Network
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68283 (2013)
Therapeutic response to selective serotonin (5-HT) reuptake inhibitors in Major Depressive Disorder (MDD) varies considerably among patients, and the onset of antidepressant therapeutic action is delayed until after 2 to 4 weeks of treatment. The obj
Externí odkaz:
https://doaj.org/article/24d5a64e84744557ad6a9850b6d11604
Autor:
Christopher R. Brydges, Oliver Fiehn, Helen S. Mayberg, Henry Schreiber, Siamak Mahmoudian Dehkordi, Sudeepa Bhattacharyya, Jungho Cha, Ki Sueng Choi, W. Edward Craighead, Ranga R. Krishnan, A. John Rush, Boadie W. Dunlop, Rima Kaddurah-Daouk, the Mood Disorders Precision Medicine Consortium
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract It is unknown whether indoles, metabolites of tryptophan that are derived entirely from bacterial metabolism in the gut, are associated with symptoms of depression and anxiety. Serum samples (baseline, 12 weeks) were drawn from participants
Externí odkaz:
https://doaj.org/article/30eb222b87c747c397003f3db5d1bac9
Autor:
Yuri Milaneschi, Matthias Arnold, Gabi Kastenmüller, Siamak Mahmoudian Dehkordi, Ranga R. Krishnan, Boadie W. Dunlop, A. John Rush, Brenda W.J.H. Penninx, Rima Kaddurah-Daouk
Publikováno v:
Journal of Affective Disorders, 307, 254-263. Elsevier
Journal of Affective Disorders
Mood Disorders Precision Medicine Consortium (MDPMC) 2022, ' Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression ', Journal of Affective Disorders, vol. 307, pp. 254-263 . https://doi.org/10.1016/j.jad.2022.03.070
J. Affect. Disord. 307, 254-263 (2022)
Journal of Affective Disorders
Mood Disorders Precision Medicine Consortium (MDPMC) 2022, ' Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression ', Journal of Affective Disorders, vol. 307, pp. 254-263 . https://doi.org/10.1016/j.jad.2022.03.070
J. Affect. Disord. 307, 254-263 (2022)
Background: Altered metabolism of acylcarnitines – transporting fatty acids to mitochondria – may link cellular energy dysfunction to depression. We examined the potential causal role of acylcarnitine metabolism in depression by leveraging genomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9843d3aee5e2f55de0f684c2af262825
https://research.vumc.nl/en/publications/560b082e-dd81-4727-9c2a-3f1caae202fa
https://research.vumc.nl/en/publications/560b082e-dd81-4727-9c2a-3f1caae202fa
Autor:
Rima Kaddurah-Daouk, Siamak Mahmoudian Dehkordi, Boadie W. Dunlop, Brenda W.J.H. Penninx, Ranga R. Krishnan, Yuri Milaneschi, Gabi Kastenmüller, Matthias Arnold, A. John Rush
BackgroundAltered metabolism of acylcarnitines – transporting fatty acids to mitochondria – may link cellular energy dysfunction to depression. We examined the potential causal role of acylcarnitine metabolism in depression by leveraging genomics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::996006831b1309a10a4f76afa9fe5032
https://doi.org/10.1101/2021.10.18.21265157
https://doi.org/10.1101/2021.10.18.21265157
Autor:
Sudeepa Bhattacharyya, Ahmed T. Ahmed, Hongjie Zhu, A. John Rush, Duan Liu, Siamak MahmoudianDehkordi, Ranga R. Krishnan, Richard M. Weinshilboum, Drew Neavin, Mark A. Frye, Matthias Arnold, Gregory Louie, Liewei Wang, Chunqiao Luo, Boadie W. Dunlop, Rima Kaddurah-Daouk
Publikováno v:
Translational Psychiatry, Vol 9, Iss 1, Pp 1-14 (2019)
Transl. Psychiatry 9:173 (2019)
Translational Psychiatry
Transl. Psychiatry 9:173 (2019)
Translational Psychiatry
Metabolomics provides valuable tools for the study of drug effects, unraveling the mechanism of action and variation in response due to treatment. In this study we used electrochemistry-based targeted metabolomics to gain insights into the mechanisms
Autor:
Boadie W. Dunlop, Lisa St. John-Williams, Michelle K. Skime, Gregory Louie, W. Edward Craighead, J. Will Thompson, Rima Kaddurah-Daouk, Mark A. Frye, Xianlin Han, Rebecca Baillie, Sudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Richard M. Weinshilboum, A. John Rush, Matthias Arnold, Patricio Riva-Posse, Ahmed T. Ahmed, M. Arthur Moseley, William M. McDonald, Ranga R. Krishnan
Publikováno v:
Translational psychiatry, vol 11, iss 1
Translational psychiatry, 11(1):153
The Mood Disorders Precision Medicine Consortium (MDPMC) 2021, ' Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression ', Translational psychiatry, vol. 11, no. 1, 153 . https://doi.org/10.1038/s41398-020-01097-6
Translational Psychiatry, Vol 11, Iss 1, Pp 1-14 (2021)
Translational Psychiatry
Transl. Psychiatry 11:153 (2021)
Translational psychiatry, 11(1):153
The Mood Disorders Precision Medicine Consortium (MDPMC) 2021, ' Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression ', Translational psychiatry, vol. 11, no. 1, 153 . https://doi.org/10.1038/s41398-020-01097-6
Translational Psychiatry, Vol 11, Iss 1, Pp 1-14 (2021)
Translational Psychiatry
Transl. Psychiatry 11:153 (2021)
Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for major depressive disorder (MDD), yet their mechanisms of action are not fully understood and their therapeutic benefit varies among individuals. We used a targeted metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de9754e2acca12abde3a737ae62b5471
https://escholarship.org/uc/item/9fc8043n
https://escholarship.org/uc/item/9fc8043n
Autor:
Siamak MahmoudianDehkordi, Mark A. Frye, A. John Rush, William M. McDonald, Xianlin Han, Gregory Louie, Ahmed T. Ahmed, Rima Kaddurah-Daouk, J. Will Thompson, Richard M. Weinshilboum, M. Arthur Moseley, Boadie W. Dunlop, Lisa St. John-Williams, W. Edward Craighead, Patricio Riva-Posse, Rebecca Baillie, Sudeepa Bhattacharyya, Michelle K. Skime, Matthias Arnold, Ranga R. Krishnan
Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for major depressive disorder (MDD), yet their mechanisms of action are not fully understood and their therapeutic benefit varies among individuals. We used a targeted metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e89911605908d0f156202c2e0a66728
Publikováno v:
2020 8th International Winter Conference on Brain-Computer Interface (BCI).
Brain-Computer Interface (BCI) technology has been under exploration as an alternative approach to restore or enhance brain functions, possibly. One of the attempts is to use BCI to help improve human cognitive functions by leveraging on the BCI capa
Autor:
Zheen Zhao, Warren D Taylor, Martin Styner, David C Steffens, K Ranga R Krishnan, James R MacFall
Publikováno v:
PLoS ONE, Vol 3, Iss 3, p e1837 (2008)
Major depression in the elderly is associated with brain structural changes and vascular lesions. Changes in the subcortical regions of the limbic system have also been noted. Studies examining hippocampus volumetric differences in depression have sh
Externí odkaz:
https://doaj.org/article/e11f4565b09e44129ebdc6cb30a4c012
Autor:
Sudeepa Bhattacharyya, Boadie W. Dunlop, Siamak Mahmoudiandehkordi, Ahmed T. Ahmed, Gregory Louie, Mark A. Frye, Richard M. Weinshilboum, Ranga R. Krishnan, A. John Rush, Helen S. Mayberg, W. Edward Craighead, Rima Kaddurah-Daouk
Publikováno v:
Frontiers in Neuroscience, Vol 13 (2019)
Frontiers in Neuroscience
Frontiers in Neuroscience
Major depressive disorder (MDD) is a common and disabling syndrome with multiple etiologies that is defined by clinically elicited signs and symptoms. In hopes of developing a list of candidate biological measures that reflect and relate closely to t